+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

Aspirin Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Aspirin Market - Forecasts from 2022 to 2027

  • Report
  • August 2022
  • 140 Pages
  • Global
From
Celiac Disease Treatment Market - Forecasts from 2018 to 2023 - Product Thumbnail Image

Celiac Disease Treatment Market - Forecasts from 2018 to 2023

  • Report
  • April 2018
  • 80 Pages
  • Global
From
Psoriatic Arthritis Treatment Market Report and Forecast 2023-2031 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 160 Pages
  • Global
From
Chondroitin Sulfate Market Report and Forecast 2023-2031 - Product Thumbnail Image

Chondroitin Sulfate Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Anti-Inflammatory Therapeutics Market 2024-2028 - Product Thumbnail Image

Anti-Inflammatory Therapeutics Market 2024-2028

  • Report
  • May 2024
  • 174 Pages
  • Global
From
Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028 - Product Thumbnail Image

Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Regional Outlook and Forecast, 2022 - 2028

  • Report
  • July 2022
  • 225 Pages
  • Global
From
Europe Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Europe Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 95 Pages
  • Europe
From
North America Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

North America Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 84 Pages
  • North America
From
LAMEA Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

LAMEA Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 95 Pages
  • Middle East, Africa
From
Asia Pacific Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028 - Product Thumbnail Image

Asia Pacific Non-steroidal Anti-inflammatory Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration (Oral, Topical and Others), By Distribution Channel, By Route of Disease Indication, By Country and Growth Forecast, 2022 - 2028

  • Report
  • July 2022
  • 96 Pages
  • Asia Pacific
From
LAMEA Uveitis Treatment Market, by Drug Class, by Disease Type, by Distribution Channel, by Country, Industry Analysis and Forecast, 2019 - 2025 - Product Thumbnail Image

LAMEA Uveitis Treatment Market, by Drug Class, by Disease Type, by Distribution Channel, by Country, Industry Analysis and Forecast, 2019 - 2025

  • Report
  • March 2020
  • 90 Pages
  • Africa, Middle East
From
Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030 - Product Thumbnail Image

Food Allergy Market Size and Trend Report including Marketed and Pipeline Drug Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2020-2030

  • Report
  • April 2022
  • 94 Pages
  • Global
From
Uveitis - Global Drug Forecast and Market Analysis to 2029 - Product Thumbnail Image

Uveitis - Global Drug Forecast and Market Analysis to 2029

  • Report
  • June 2021
  • Global
From
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028 - Product Thumbnail Image

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • Report
  • October 2019
  • 128 Pages
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 77 Pages
  • Global
From
Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Uveitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • June 2022
  • 176 Pages
  • Global
From
Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021 - Product Thumbnail Image

Rheumatoid Arthritis (Immunology) - Drugs in Development, 2021

  • Drug Pipelines
  • March 2021
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Rheumatoid Arthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Rheumatoid Arthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 1191 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more